Detalhe da pesquisa
1.
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma.
Cell
; 171(2): 481-494.e15, 2017 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28985567
2.
Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.
Cancer
; 2024 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38630908
3.
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
Blood
; 137(3): 374-386, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663292
4.
Older patients with primary central nervous system lymphoma: Survival and prognostication across 20 U.S. cancer centers.
Am J Hematol
; 98(6): 900-912, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36965007
5.
Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial.
Lancet Oncol
; 23(8): 1021-1030, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835137
6.
Ofatumumab plus HyperCVAD/HD-MA induction leads to high rates of minimal residual disease negativity in patients with newly diagnosed mantle cell lymphoma: Results of a phase 2 study.
Cancer
; 128(8): 1595-1604, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35157306
7.
How we treat advanced stage cutaneous T-cell lymphoma - mycosis fungoides and Sézary syndrome.
Br J Haematol
; 195(3): 352-364, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33987825
8.
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab.
Blood
; 133(19): 2031-2042, 2019 05 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842083
9.
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Haematologica
; 106(7): 1932-1942, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538152
10.
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
Cancer
; 126(2): 293-303, 2020 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31568564
11.
Outcomes and Toxicities of Programmed Death-1 (PD-1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real-World, Multicenter Retrospective Analysis.
Oncologist
; 24(7): 955-962, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30568021
12.
Impact of ibrutinib dose adherence on therapeutic efficacy in patients with previously treated CLL/SLL.
Blood
; 129(19): 2612-2615, 2017 05 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28373262
13.
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019.
J Natl Compr Canc Netw
; 17(6): 650-661, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200358
14.
Outcomes with ibrutinib by line of therapy and post-ibrutinib discontinuation in patients with chronic lymphocytic leukemia: Phase 3 analysis.
Am J Hematol
; 94(5): 554-562, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30767298
15.
Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma.
Am J Hematol
; 94(12): 1353-1363, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31512258
16.
Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab.
J Oncol Pharm Pract
; 25(3): 706-709, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-29334337
17.
Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancer.
J Oncol Pharm Pract
; 25(8): 1927-1932, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30880568
18.
Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study.
Biol Blood Marrow Transplant
; 24(3): 486-493, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29225164
19.
R-CHOP versus dose-adjusted R-EPOCH in frontline management of primary mediastinal B-cell lymphoma: a multi-centre analysis.
Br J Haematol
; 180(4): 534-544, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29265182
20.
Clinical Practice Recommendations on Indication and Timing of Hematopoietic Cell Transplantation in Mature T Cell and NK/T Cell Lymphomas: An International Collaborative Effort on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 23(11): 1826-1838, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28797780